Health
Oncoclínicas Group generated record earnings in the second quarter of 2023, R$309 million and a net profit of R$35 million
Efficient management of working capital explains a large part of the cash flow performance. Net income grew 51% (31% organically) while the Ebitda Ex-LTIP (excluding only the non-cash impact of the long-term incentive plan) reached R$268 million, 109% greater than the same period last year SÃO PA...
2023-08-16 19:00
1907
"Pink Walk 2023" - signature charity walk of Hong Kong Breast Cancer Foundation is making a comeback on 15 October at the Peak
"Step Up for Breast Health"! HONG KONG, Aug. 16, 2023 /PRNewswire/ -- The Hong Kong Breast Cancer Foundation (HKBCF), is delighted to announce that its annual signature fundraising event"Pink Walk 2023" is making a comeback on 15 October 2023 (Sunday) at The Peak,Hong Kong Island. Themed "Step U...
2023-08-16 17:16
2409
Record number of participants expected at Medlab Asia & Asia Health 2023
BANGKOK, Aug. 16, 2023 /PRNewswire/ -- Medlab Asia & Asia Health 2023, organised by Informa Markets and IMPACT Exhibition Management in collaboration with the Central Sterilizing Services Association, has officially opened to showcase the latest techniques and innovations in the healthcare and lab...
2023-08-16 16:08
2480
Nippon Express (Ireland) Opens New Warehouse in Dublin, Beginning Operations July 1
TOKYO, Aug. 16, 2023 /PRNewswire/ -- Nippon Express (Ireland) Ltd. (hereafter "NX Ireland"), a group company of NIPPON EXPRESS HOLDINGS, INC., has established a new warehouse, "Contract Logistics Center," inDublin city, beginning its operations onJuly 1. Logo: https://kyodonewsprwire.jp/img/2023...
2023-08-16 14:00
1788
Daewoong Pharmaceutical Initiates Global Export of 'Novel Drug' Launching 'Fexuprazan' in the Philippines
'Fexuprazan,' Novel drug for Gastroesophageal Reflux Disease, starts its release inthe Philippines... The first case of overseas launch SEOUL, South Korea, Aug. 16, 2023 /PRNewswire/ -- Daewoong Pharmaceutical (CEO Jeon Seng-ho, Lee Chang-jae) announced that 'Fuxuprazan' is officially launched i...
2023-08-16 13:00
2588
MGI Unveils Latest MGISP-NEX and MGIFLP-L50 Automation Systems at Medlab Asia & Asia Health 2023
BANGKOK, Thailand, Aug. 16, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced the global launch of MGISP-NEX and MGIFLP-L50 automation platforms at Medlab Asia & Asia Health 2023, taking place from 16-18 August at IMPACT E...
2023-08-16 11:00
2327
GLENEAGLES HOSPITAL MEDINI JOHOR AND THE INTERNATIONAL WOMEN'S PEACE GROUP ORGANIZE TALK FOR 200 JOHOR EDUCATORS
Key Speakers Provide Invaluable Insights for Addressing Adolescent Reproductive Health Issues ISKANDAR PUTERI, Malaysia, Aug. 16, 2023 /PRNewswire/ -- Gleneagles Hospital Medini Johor (GHMJ) and the International Women's Peace Group (IWPG) have reaffirmed their shared commitment to the well...
2023-08-16 10:59
2100
Charmacy Pharmaceutical Has Obtained the Provincial Capital Support
Future Expected Rapidly Growth HONG KONG, Aug. 16, 2023 /PRNewswire/ -- Charmacy Pharmaceutical Co., LTD. ( Charmacy Pharmaceutical, stock code: 2289.HK), as a leading private pharmaceutical distributor inSouth China, has been actively seeking strategic cooperation and resource complementary fro...
2023-08-16 09:00
3757
Infinitus and Jiangnan University Establish an Innovation Research Center to Explore the Combination of Chinese Herbal Medicine and Probiotics
GUANGZHOU, China, Aug. 16, 2023 /PRNewswire/ -- On August 10, the signing and
inauguration ceremony ofthe Infinitus-Jiangnan University Chinese Herbal +
Probiotics Collaborative Innovation Research Center was held at Infinitus Plaza.
2023-08-16 08:00
2160
Transcenta to Present Three Study Results at ESMO 2023
SUZHOU, China, Aug. 16, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it is going to ...
2023-08-16 08:00
1831
MedAlliance announces the completion of enrollment in SAVE Trial with SELUTION SLR for Treatment of AV Fistulas in Renal Dialysis Patients
GENEVA, Aug. 16, 2023 /PRNewswire/ -- MedAlliance has announced completion of patient enrollment in the SAVE Clinical Trial with the SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment of failed AVF (arteriovenous fistulas) in renal dialysis patients. SELUTION SLR is a novel sirolimus-...
2023-08-16 08:00
1801
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024
Pipeline makes progress towards commercialization as robust demand for YSJA rabies vaccine continues Gross margin increases to 80.3%; balance sheet remains strong GAITHERSBURG, Md., Aug. 16, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biop...
2023-08-16 05:00
2684
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024
Pipeline makes progress towards commercialization as robust demand for YSJA rabies vaccine continues Gross margin increases to 80.3%; balance sheet remains strong GAITHERSBURG, Md., Aug. 15, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biop...
2023-08-16 05:00
3157
CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency
The MOU signed by CytoMed and Hangzhou CNK Therapeutics Co., Ltd is the first
of several collaborative efforts inNorth Asia.
SINGAPORE, Aug. 15, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited
2023-08-16 01:00
2152
Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis
SAN DIEGO, SHANGHAI and SYDNEY, Aug. 15, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, announced that the first patient has been dosed in a glob...
2023-08-15 22:50
2313
CStone Pharmaceuticals Reports 2023 Interim Results and Updates
* The total revenue was RMB 261.5 million for the six months ended June 30, 2023. The sales of pharmaceutical products revenue was RMB 246.9 million, representing a growth rate of 53% compared to the same period last year. Commercial gross profit margin improved from 47% to 59%. * Healthy fin...
2023-08-15 22:33
3866
Everest Medicines' Partner Venatorx Receives FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI)
SHANGHAI, Aug. 15, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK)'s partner Venatorx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for cefepime-taniborbactam, an investigational beta-lactam/beta-lactamase in...
2023-08-15 20:19
2030
OnCusp Therapeutics Receives FDA Clearance for the Phase 1 Clinical Trial of CUSP06, Targeting Ovarian Cancer and Other Advanced Solid Tumors
NEW YORK, Aug. 15, 2023 /PRNewswire/ -- OnCusp Therapeutics, a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide, announced today the clearance of its Investigational New Drug (IND) Applicatio...
2023-08-15 20:00
1134
Former U.S. Representative Patrick J. Kennedy Joins Holmusk as a Strategic Advisor
Kennedy to champion development of measurement standards to improve behavioral
health care
NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Holmusk
2023-08-15 20:00
1366
Hong Kong Department of Health has Approved the Registration Applications for the Uro-G and Uro-V Disposable Cystoscopic System
SHANGHAI, Aug. 15, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the Government of Hong Kong Specia...
2023-08-15 16:52
1882
Week's Top Stories
Most Reposted
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
[Picked up by 350 media titles]
2024-09-18 11:30
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
[Picked up by 315 media titles]
2024-09-16 11:50
Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
[Picked up by 284 media titles]
2024-09-14 17:37
Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture
[Picked up by 283 media titles]
2024-09-19 14:00
Watsons-Marlow unveils Qdos™ H-FLO and WMArchitectTM :Innovating fluid solutions for the chemical and biopharmaceutical industries respectively
[Picked up by 274 media titles]
2024-09-19 08:00
Most Read
Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
2024-09-14 17:37
10085
Maiji Mountain Grottoes: Carved in stone, evolving in time
2024-09-14 13:23
8505
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
2024-09-16 11:50
8440
Vision China: US, China urged to find right path in ties
2024-09-14 01:10
8013
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
2024-09-18 11:30
7336